AIM IMMUNOTECH INC. Derivative Liability, Noncurrent
AIM IMMUNOTECH INC. (AIM) had Derivative Liability, Noncurrent of $8.24 million as of 2025-12-31, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-07
- 2025-12-31: Derivative Liability, Noncurrent $8.24M.
- 2025-09-30: Derivative Liability, Noncurrent $7.30M.
- 2015-09-30: Derivative Liability, Noncurrent $0.00.
- 2015-06-30: Derivative Liability, Noncurrent $0.00.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2025-12-31 | $8.24M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $7.30M 10-Q · filed 2025-11-17 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-16 |
| 2014-09-30 | $13.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $13.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $14.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $14.00K 10-K · filed 2015-03-19 |
| 2013-09-30 | $66.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $104.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $206.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $295.00K 10-K · filed 2014-03-14 |
| 2012-09-30 | $2.11M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $144.00K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $531.00K 10-Q · filed 2012-05-07 |
| 2011-12-31 | $380.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $1.25M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.86M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $2.81M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |